valdecoxib has been researched along with zm 336372 in 1 studies
| Studies (valdecoxib) | Trials (valdecoxib) | Recent Studies (post-2010) (valdecoxib) | Studies (zm 336372) | Trials (zm 336372) | Recent Studies (post-2010) (zm 336372) |
|---|---|---|---|---|---|
| 375 | 71 | 86 | 27 | 0 | 11 |
| Protein | Taxonomy | valdecoxib (IC50) | zm 336372 (IC50) |
|---|---|---|---|
| Receptor-interacting serine/threonine-protein kinase 2 | Homo sapiens (human) | 100 | |
| RAF proto-oncogene serine/threonine-protein kinase | Homo sapiens (human) | 0.0603 | |
| Proto-oncogene tyrosine-protein kinase LCK | Mus musculus (house mouse) | 0.57 | |
| Serine/threonine-protein kinase B-raf | Homo sapiens (human) | 0.23 | |
| Delta-type opioid receptor | Mus musculus (house mouse) | 0.18 | |
| Mitogen-activated protein kinase 11 | Homo sapiens (human) | 2 | |
| Mitogen-activated protein kinase 14 | Homo sapiens (human) | 1.09 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bilter, GK; Dias, J; Huang, Z; Keon, BH; Lamerdin, J; MacDonald, ML; Michnick, SW; Minami, T; Owens, S; Shang, Z; Westwick, JK; Yu, H | 1 |
1 other study(ies) available for valdecoxib and zm 336372
| Article | Year |
|---|---|
Identifying off-target effects and hidden phenotypes of drugs in human cells.
Topics: Bacterial Proteins; Cell Line; Cell Proliferation; Cluster Analysis; Drug Design; Drug Evaluation, Preclinical; Genetics; Humans; Luminescent Proteins; Molecular Structure; Phenotype; Recombinant Fusion Proteins; Signal Transduction; Structure-Activity Relationship | 2006 |